It has been used to reverse pulmonary hypertension caused by [[protamine]] (which in turn was administered to reverse the effects of [[heparin]] overdose).<ref name="pmid8969033">{{cite journal |vauthors=van der Starre PJ, Solinas C |title=Ketanserin in the treatment of protamine-induced pulmonary hypertension |journal=Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital |volume=23 |issue=4 |pages=301–4 |year=1996 |pmid=8969033 |pmc=325377 |doi= |url=}}</ref>

 
Ketanserin is a high-affinity non-selective [[receptor antagonist|antagonist]] of [[5-HT2 receptor|5-HT<sub>2</sub> receptors]] in rodents,<ref name="NIMH-PDSP">[http://pdsp.med.unc.edu/ NIMH Psychoactive Drug Screening Program]</ref><ref>{{cite journal | title=Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats |author1=Creed-Carson M |author2=Oraha A. Norbrega JN. | journal=Behav Brain Res | url=http://www.sciencedirect.com/science/article/pii/S0166432811000519 | volume=219 | pages = 273–279 | year = 2011 | doi = 10.1016/j.bbr.2011.01.025 | pmid =21262266}}</ref> with K<sub>i</sub> values of 2–3&nbsp;nM for the 5-HT<sub>2A</sub> receptor and 28&nbsp;nM for the 5-HT<sub>2C</sub> receptor).<ref name="NIMH-PDSP"/><ref name="Meneses2014">{{cite book|author=Alfredo Meneses|title=The Role of 5-HT Systems on Memory and Dysfunctional Memory: Emergent Targets for Memory Formation and Memory Alterations|url=https://books.google.com/books?id=x_TJAgAAQBAJ&pg=PA23|date=11 March 2014|publisher=Elsevier Science|isbn=978-0-12-801083-9|pages=23–}}</ref> In primates including humans however, ketanserin is a more selective antagonist of the 5-HT<sub>2A</sub> over the 5-HT<sub>2C</sub> receptor,<ref name="NIMH-PDSP"/> with K<sub>i</sub> values of 2–3&nbsp;nM for the  5-HT<sub>2A</sub>receptor and 130&nbsp;nM for the 5-HT<sub>2C</sub> receptor.<ref name="NIMH-PDSP"/> In addition to the 5-HT<sub>2</sub> receptors, ketanserin is also a high affinity antagonist for the [[H1 receptor|H<sub>1</sub> receptor]] (K<sub>i</sub> = 2 nM),<ref name="NIMH-PDSP" /><ref name="Coyne2008">{{cite book|author=C.P. Coyne|title=Comparative Diagnostic Pharmacology: Clinical and Research Applications in Living-System Models|url=https://books.google.com/books?id=Kar-JGFMe-AC&pg=PA104|date=9 January 2008|publisher=John Wiley & Sons|isbn=978-0-470-34429-3|pages=104–}}</ref> and has measurable albeit relatively low affinity for a number of other receptors:
